Per Morten Sandset
Position: Head of Research, Professor
Phone: +47 97591745
Email:

Professor Per Morten Sandset is leading the groups that focus on thrombosis and haemostasis:

 

Author network for Per Morten Sandset by COREMINE medical


Publications 2017

Andresen MS, Ali HO, Myklebust CF, Sandset PM, Stavik B, Iversen N, Skretting G (2017)
Estrogen induced expression of tissue factor pathway inhibitor-2 in MCF7 cells involves lysine-specific demethylase 1
Mol Cell Endocrinol, 443, 80-88
PubMed 28088469

Cui XY, Skretting G, Tinholt M, Stavik B, Dahm AEA, Sahlberg KK, Kanse S, Iversen N, Sandset PM (2017)
A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7
Thromb Res, 157, 111-116
PubMed 28734156

Espada S, Stavik B, Holm S, Sagen EL, Bjerkeli V, Skjelland M, Dahl TB, Espevik T, Kanse S, Sandset PM, Skretting G, Halvorsen B (2017)
Tissue factor pathway inhibitor attenuates ER stress-induced inflammation in human M2-polarized macrophages
Biochem Biophys Res Commun, 491 (2), 442-448
PubMed 28712870

Gravensteen IK, Jacobsen EM, Sandset PM, Helgadottir LB, Rådestad I, Sandvik L, Ekeberg Ø (2017)
Healthcare utilisation, induced labour and caesarean section in the pregnancy after stillbirth: a prospective study
BJOG (in press)
PubMed 28516500

Krishnan K, Jusufovic M, Sandset PM, Sandset EC (2017)
Antiplatelet Therapy in Noncardioembolic Stroke: A Review of Current Evidence
Semin Neurol, 37 (3), 366-375
PubMed 28759917

Prebensen C, Trøseid M, Ueland T, Dahm A, Sandset PM, Aaberge I, Waalen K, Dyrhol-Riise AM, Taskén K, Kvale D (2017)
Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
PLoS One, 12 (5), e0176527
PubMed 28464042

Schultz NH, Tran HTT, Bjørnsen S, Henriksson CE, Sandset PM, Holme PA (2017)
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
Thromb J, 15, 6
PubMed 28239301

Stavik B, Holm S, Espada S, Iversen N, Sporsheim B, Bjerkeli V, Dahl TB, Sandset PM, Skjelland M, Espevik T, Skretting G, Halvorsen B (2017)
Increased expression of TFPI in human carotid stenosis
Thromb Res, 155, 31-37
PubMed 28482260

Tikkinen KAO, Craigie S, Agarwal A, Siemieniuk RAC, Cartwright R, Violette PD, Novara G, Naspro R, Agbassi C, Ali B, Imam M, Ismaila N, Kam D, Gould MK, Sandset PM, Guyatt GH (2017)
Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysis
Eur Urol (in press)
PubMed 28284738

Tikkinen KAO, Craigie S, Agarwal A, Violette PD, Novara G, Cartwright R, Naspro R, Siemieniuk RAC, Ali B, Eryuzlu L, Geraci J, Winkup J, Yoo D, Gould MK, Sandset PM, Guyatt GH (2017)
Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysis
Eur Urol (in press)
PubMed 28342641

Wik HS, Ghanima W, Sandset PM, Kahn SR (2017)
Scoring Systems for Postthrombotic Syndrome
Semin Thromb Hemost, 43 (5), 500-504
PubMed 28470653

Publications 2016

Ali HO, Arroyo AB, González-Conejero R, Stavik B, Iversen N, Sandset PM, Martínez C, Skretting G (2016)
The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α
J Thromb Haemost, 14 (6), 1226-37
PubMed 26999003

Ali HO, Stavik B, Myklebust CF, Andersen E, Dahm AE, Iversen N, Sandset PM, Skretting G (2016)
Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region
PLoS One, 11 (3), e0152114
PubMed 26999742

Arntzen E, Sandset PM (2016)
[Not Available]
Tidsskr Nor Laegeforen, 136 (12-13), 1062
PubMed 27381773

Arntzen E, Sandset PM (2016)
[Specialist training for physicians - clear responsibility, better quality]
Tidsskr Nor Laegeforen, 136 (10), 898-9
PubMed 27272365

Bates SM, Alonso-Coello P, Tikkinen KA, Ebrahim S, Lopes LC, McDonald SD, Zhou Q, Akl EA, Neumann I, Jacobsen AF, Zhang Y, Santamaría A, Annichino-Bizzacchi JM, Sandset PM, Bitar W, Eckman MH, Guyatt GH (2016)
Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview
Thromb Res, 140, 22-9
PubMed 27500301

Cui XY, Tinholt M, Stavik B, Dahm AE, Kanse S, Jin Y, Seidl S, Sahlberg KK, Iversen N, Skretting G, Sandset PM (2016)
Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer
J Thromb Haemost, 14 (2), 387-96
PubMed 26598923

Garabet L, Gilboe IM, Mowinckel MC, Jacobsen AF, Mollnes TE, Sandset PM, Jacobsen EM (2016)
Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
Scand J Immunol, 84 (2), 95-9
PubMed 27135178

Haig Y, Enden T, Grøtta O, Kløw NE, Slagsvold CE, Ghanima W, Sandvik L, Hafsahl G, Holme PA, Holmen LO, Njaaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2016)
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
Lancet Haematol, 3 (2), e64-71
PubMed 26853645

Martin K, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S (2016)
Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
J Thromb Haemost, 14 (6), 1308-13
PubMed 27299806

Stavik B, Espada S, Cui XY, Iversen N, Holm S, Mowinkel MC, Halvorsen B, Skretting G, Sandset PM (2016)
EPAS1/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells
Biochim Biophys Acta, 1862 (4), 670-8
PubMed 26826018

Tavoly M, Utne KK, Jelsness-Jørgensen LP, Wik HS, Klok FA, Sandset PM, Ghanima W (2016)
Health-related quality of life after pulmonary embolism: a cross-sectional study
BMJ Open, 6 (11), e013086
PubMed 27810979

Tinholt M, Sandset PM, Iversen N (2016)
Polymorphisms of the coagulation system and risk of cancer
Thromb Res, 140 Suppl 1, S49-54
PubMed 27067978

Tinholt M, Sandset PM, Mowinckel MC, Garred Ø, Sahlberg KK, Kristensen VN, Børresen-Dale AL, Jacobsen AF, Skretting G, Iversen N (2016)
Determinants of acquired activated protein C resistance and D-dimer in breast cancer
Thromb Res, 145, 78-83
PubMed 27505249

Tiscia GL, Dørum E, Myklebust CF, Grandone E, Sandset PM, Skretting G (2016)
Functional characterization of annexin A5 gene promoter allelic variants
Thromb Res, 144, 93-9
PubMed 27318245

Utne KK, Tavoly M, Wik HS, Jelsness-Jørgensen LP, Holst R, Sandset PM, Ghanima W (2016)
Health-related quality of life after deep vein thrombosis
Springerplus, 5 (1), 1278
PubMed 27547653

Publications 2015

Beitland S, Sandven I, Kjærvik LK, Sandset PM, Sunde K, Eken T (2015)
Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis
Intensive Care Med, 41 (7), 1209-19
PubMed 25971389

Berntsen CF, Kristiansen A, Akl EA, Sandset PM, Jacobsen EM, Guyatt G, Vandvik PO (2015)
Compression Stockings for Preventing the Postthrombotic Syndrome in Patients with Deep Vein Thrombosis
Am J Med, 129 (4), 447.e1-447.e20
PubMed 26747198

Chollet ME, Skarpen E, Iversen N, Sandset PM, Skretting G (2015)
The chemical chaperone sodium 4-phenylbutyrate improves the secretion of the protein CA267T mutant in CHO-K1 cells trough the GRASP55 pathway
Cell Biosci, 5, 57
PubMed 26457178

Comerota AJ, Sandset PM, Konstantinides S, de Graaf R, Wakefield TW, Arnoldussen CW, Lam YL, van Gent WB, de Wolf MA, Catarinella FS, Kurstjens RL, Alshabatat A, Wittens CH (2015)
Theme 4: Invasive management of (recurrent) VTE and PTS
Thromb Res, 136 Suppl 1, S19-25
PubMed 26387732

Craigie S, Tsui JF, Agarwal A, Sandset PM, Guyatt GH, Tikkinen KA (2015)
Adherence to mechanical thromboprophylaxis after surgery: A systematic review and meta-analysis
Thromb Res, 136 (4), 723-6
PubMed 26140737

Dahm AE, Tiscia G, Holmgren A, Jacobsen AF, Skretting G, Grandone E, Sandset PM (2015)
Genetic variations in the annexin A5 gene and the risk of pregnancy-related venous thrombosis
J Thromb Haemost, 13 (3), 409-13
PubMed 25495894

Eckman MH, Alonso-Coello P, Guyatt GH, Ebrahim S, Tikkinen KA, Lopes LC, Neumann I, McDonald SD, Zhang Y, Zhou Q, Akl EA, Jacobsen AF, Santamaría A, Annichino-Bizzacchi JM, Bitar W, Sandset PM, Bates SM (2015)
Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities
Thromb Res, 136 (2), 341-7
PubMed 26033397

Iversen PO, Dahm A, Skretting G, Mowinckel MC, Stranda A, Østerud B, Sandset PM, Kostovski E (2015)
Reduced peak, but no diurnal variation, in thrombin generation upon melatonin supplementation in tetraplegia. A randomised, placebo-controlled study
Thromb Haemost, 114 (5), 964-8
PubMed 26202881

Johnson KC, Aragaki AK, Jackson R, Reiner A, Sandset PM, Rosing J, Dahm AE, Rosendaal F, Manson JE, Martin LW, Liu S, Kuller LH, Cushman M, Rossouw JE (2015)
Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin Therapy
Arterioscler Thromb Vasc Biol, 36 (2), 418-24
PubMed 26681757

Kostovski E, Dahm AE, Mowinckel MC, Stranda A, Skretting G, Østerud B, Sandset PM, Iversen PO (2015)
Circadian rhythms of hemostatic factors in tetraplegia: a double-blind, randomized, placebo-controlled cross-over study of melatonin
Spinal Cord, 53 (4), 285-90
PubMed 25644388

Sandset EC, Jusufovic M, Sandset PM, Bath PM, Berge E, SCAST Study Group (2015)
Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke
Stroke, 46 (3), 877-9
PubMed 25657183

Stiksrud B, Nowak P, Nwosu FC, Kvale D, Thalme A, Sonnerborg A, Ueland PM, Holm K, Birkeland SE, Dahm AE, Sandset PM, Rudi K, Hov JR, Dyrhol-Riise AM, Trøseid M (2015)
Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
J Acquir Immune Defic Syndr, 70 (4), 329-37
PubMed 26258571

Tinholt M, Stavik B, Louch W, Carlson CR, Sletten M, Ruf W, Skretting G, Sandset PM, Iversen N (2015)
Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells
PLoS One, 10 (1), e0117404
PubMed 25617766

Tinholt M, Vollan HK, Sahlberg KK, Jernström S, Kaveh F, Lingjærde OC, Kåresen R, Sauer T, Kristensen V, Børresen-Dale AL, Sandset PM, Iversen N (2015)
Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
Breast Cancer Res, 17, 44
PubMed 25882602

Utne KK, Ghanima W, Foyn S, Kahn S, Sandset PM, Wik HS (2015)
Development and validation of a tool for patient reporting of symptoms and signs of the post-thrombotic syndrome
Thromb Haemost, 115 (2), 361-7
PubMed 26422814

Wik HS, Jacobsen AF, Mowinckel MC, Sandset PM (2015)
The role of inflammation in post-thrombotic syndrome after pregnancy-related deep vein thrombosis: A population-based, cross-sectional study
Thromb Res, 138, 16-21
PubMed 26826503

Wik HS, Jacobsen AF, Sandset PM (2015)
Long-term outcome after pregnancy-related venous thrombosis
Thromb. Res., 135 1, S1-S4

Publications 2014

Ali HO, Stavik B, Dørum E, Iversen N, Sandset PM, Skretting G (2014)
Oestrogen induced downregulation of TFPI expression is mediated by ERα
Thromb Res, 134 (1), 138-43
PubMed 24785473

Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE (2014)
Residual rates of reflux and obstruction and their correlation to post-thrombotic syndrome in a randomized study on catheter-directed thrombolysis for deep vein thrombosis
J Vasc Surg Venous Lymphat Disord, 2 (2), 123-30
PubMed 26993176

Jacobsen AF, Kristiansen A, Bjørge L, Henriksen T, Eilertsen AL, Sandset PM (2014)
[Anticoagulation for venous thrombosis in pregnancy]
Tidsskr Nor Laegeforen, 134 (9), 926
PubMed 24828717

Jacobsen EM, Dahm AE, Vartdal T, Sandset PM (2014)
[Anticoagulation for venous thrombosis and internal diseases]
Tidsskr Nor Laegeforen, 134 (9), 924
PubMed 24828715

Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Bondi J, Dahm AE, Granan LP, Halvorsen S, Holme PA, Flem Jacobsen A, Jacobsen EM, Neumann I, Sandset PM, Sætre T, Tveit A, Vartdal T, Guyatt G, Vandvik PO (2014)
Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process
Chest, 146 (3), 727-734
PubMed 25180723

Kristiansen A, Brandt L, Berge E, Dahm AE, Halvorsen S, Sandset PM, Vandvik PO (2014)
[New guidelines for antithrombotic therapy and thromboprophylaxis]
Tidsskr Nor Laegeforen, 134 (9), 921-2
PubMed 24828713

Pitkänen H, Jouppila A, Mowinckel MC, Lemponen M, Patiwael S, Sandset PM, Lassila R, Brinkman HJ (2014)
Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma
Thromb Res, 135 (1), 167-74
PubMed 25466844

Sandset PM (2014)
Combined oral contraceptives increase risk of venous thrombosis according to oestrogen dose and type of progestogen
Evid Based Med, 19 (5), 194
PubMed 24948124

Subramaniam S, Thielmann I, Morowski M, Pragst I, Sandset PM, Nieswandt B, Etscheid M, Kanse SM (2014)
Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP)
Thromb Haemost, 113 (4), 870-80
PubMed 25427855

Tavoly M, Jelsness-Jørgensen LP, Wik HS, Roaldsnes C, Sandset PM, Ghanima W (2014)
Quality of life after pulmonary embolism: first cross-cultural evaluation of the pulmonary embolism quality-of-life (PEmb-QoL) questionnaire in a Norwegian cohort
Qual Life Res, 24 (2), 417-25
PubMed 25120017

Tikkinen KA, Agarwal A, Craigie S, Cartwright R, Gould MK, Haukka J, Naspro R, Novara G, Sandset PM, Siemieniuk RA, Violette PD, Guyatt GH (2014)
Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology
Syst Rev, 3, 150
PubMed 25540016

Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N (2014)
Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
BMC Cancer, 14, 845
PubMed 25407022

Publications 2013

Cui XY, Skretting G, Jing Y, Sun H, Sandset PM, Sun L (2013)
Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells
Blood Cells Mol Dis, 51 (3), 177-84
PubMed 23725749

Enden T, Kløw NE, Sandset PM (2013)
Symptom burden and job absenteeism after treatment with additional catheter-directed thrombolysis for deep vein thrombosis
Patient Relat Outcome Meas, 4, 55-9
PubMed 24082798

Enden T, Resch S, White C, Wik HS, Kløw NE, Sandset PM (2013)
Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis
J Thromb Haemost, 11 (6), 1032-42
PubMed 23452204

Enden T, Wik HS, Kvam AK, Haig Y, Kløw NE, Sandset PM (2013)
Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study
BMJ Open, 3 (8), e002984
PubMed 23988361

Ghanima W, Atar D, Sandset PM (2013)
New oral anticoagulants--a review
Tidsskr Nor Laegeforen, 133 (18), 1940-5
PubMed 24084970

Gravensteen IK, Helgadóttir LB, Jacobsen EM, Rådestad I, Sandset PM, Ekeberg O (2013)
Women's experiences in relation to stillbirth and risk factors for long-term post-traumatic stress symptoms: a retrospective study
BMJ Open, 3 (10), e003323
PubMed 24154514

Helgadóttir LB, Turowski G, Skjeldestad FE, Jacobsen AF, Sandset PM, Roald B, Jacobsen EM (2013)
Classification of stillbirths and risk factors by cause of death--a case-control study
Acta Obstet Gynecol Scand, 92 (3), 325-33
PubMed 23157574

Iversen PO, Negaard H, Østenstad B, Sandset PM, Kolset SO (2013)
Evidence for long-term hypercoagulopathy, but normalization of markers of extracellular matrix turnover, in patients with non-Hodgkin lymphoma
Leuk Lymphoma, 56 (8), 2479-81
PubMed 23656198

Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, Reitsma P, Sandset PM, van Vliet HA (2013)
The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI
Thromb Haemost, 109 (4), 606-13
PubMed 23407778

Sandset PM (2013)
Genotype of proband and thrombophilia screening
Blood, 122 (15), 2528-9
PubMed 24113791

Sandset PM (2013)
Mechanisms of hormonal therapy related thrombosis
Thromb Res, 131 Suppl 1, S4-7
PubMed 23452740

Stavik B, Tinholt M, Sletten M, Skretting G, Sandset PM, Iversen N (2013)
TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity
J Hematol Oncol, 6, 5
PubMed 23320987

Whiteley WN, Adams HP, Bath PM, Berge E, Sandset PM, Dennis M, Murray GD, Wong KS, Sandercock PA (2013)
Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials
Lancet Neurol, 12 (6), 539-45
PubMed 23642343

Wik HS, Jacobsen AF, Fagerland MW, Sandvik L, Sandset PM (2013)
Long-term mortality and incidence of cancer after pregnancy-related venous thrombosis: results of a population-based cohort study
Thromb Res, 131 (6), 497-501
PubMed 23726964

Aamodt AH, Sandset PM, Atar D, Tveit A, Russell D (2013)
[Atrial fibrillation and stroke]
Tidsskr Nor Laegeforen, 133 (14), 1453-7
PubMed 23929293

Publications 2012

Bergrem A, Dahm AE, Jacobsen AF, Sandvik L, Sandset PM (2012)
Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study
Thromb Haemost, 108 (6), 1165-71
PubMed 23015030

Dahm AE, Bezemer ID, Bergrem A, Jacobsen AF, Jacobsen EM, Skretting G, Rosendaal FR, Sandset PM (2012)
Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis
Br J Haematol, 157 (6), 753-61
PubMed 22533697

Dahm AE, Eilertsen AL, Goeman J, Olstad OK, Ovstebø R, Kierulf P, Mowinckel MC, Skretting G, Sandset PM (2012)
A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women
Thromb Res, 130 (1), 45-51
PubMed 22217510

Enden T, Klow NE, Sandset PM (2012)
Catheter-directed thrombolysis for acute deep vein thrombosis Reply
Lancet, 379 (9828), 1786-1787

Enden T, Sandset PM, Kløw NE (2012)
Evidence-based practice for patients with severe venous thrombosis
Tidsskr Nor Laegeforen, 132 (10), 1215-6
PubMed 22669381

Ghanima W, Lee SY, Barsam S, Miller A, Sandset PM, Bussel JB (2012)
Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists
Br J Haematol, 158 (6), 811-4
PubMed 22816787

Gravensteen IK, Helgadottir LB, Jacobsen EM, Sandset PM, Ekeberg Ø (2012)
Long-term impact of intrauterine fetal death on quality of life and depression: a case-control study
BMC Pregnancy Childbirth, 12, 43
PubMed 22676992

Haig Y, Enden T, Slagsvold CE, Sandvik L, Sandset PM, Kløw NE (2012)
Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis
J Vasc Interv Radiol, 24 (1), 17-24; quiz 26
PubMed 23176966

Jacobsen AF, Sandset PM (2012)
Venous thromboembolism associated with pregnancy and hormonal therapy
Best Pract Res Clin Haematol, 25 (3), 319-32
PubMed 22959548

Narverud I, Iversen PO, Aukrust P, Halvorsen B, Ueland T, Johansen SG, Nenseter MS, Sandset PM, Ulven SM, Ose L, Retterstøl K, Holven KB (2012)
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
Thromb Res, 131 (2), 178-82
PubMed 23199546

Rossouw JE, Johnson KC, Pettinger M, Cushman M, Sandset PM, Kuller L, Rosendaal F, Rosing J, Wasserthal-Smoller S, Martin LW, Manson JE, Lakshminarayan K, Merino JG, Lynch J (2012)
Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy
Stroke, 43 (4), 952-7
PubMed 22363056

Sandset PM (2012)
CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer
Thromb Res, 129 Suppl 1, S97-100
PubMed 22682144

Skretting G, Iversen N, Myklebust CF, Dahm AE, Sandset PM (2012)
Overexpression of tissue factor pathway inhibitor in CHO-K1 cells results in increased activation of NF-κB and apoptosis mediated by a caspase-3 independent pathway
Mol Biol Rep, 39 (12), 10089-96
PubMed 22932941

Stavik B, Skretting G, Olstad OK, Sletten M, Dehli Vigeland M, Sandset PM, Iversen N (2012)
TFPI alpha and beta regulate mRNAs and microRNAs involved in cancer biology and in the immune system in breast cancer cells
PLoS One, 7 (10), e47184
PubMed 23071754

Vandvik PO, Sandset PM (2012)
[Confusion regarding evidence-based advice]
Tidsskr Nor Laegeforen, 132 (10), 1204
PubMed 22669369

Wik HS, Jacobsen AF, Sandvik L, Sandset PM (2012)
Long-term impact of pregnancy-related venous thrombosis on quality-of-life, general health and functioning: results of a cross-sectional, case-control study
BMJ Open, 2 (6)
PubMed 23144263

Wik HS, Jacobsen AF, Sandvik L, Sandset PM (2012)
Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study
J Thromb Haemost, 10 (5), 840-7
PubMed 22452811

Publications 2011

Alatri A, Armstrong AE, Greinacher A, Koster A, Kozek-Langenecker SA, Lancé MD, Link A, Nielsen JD, Sandset PM, Spanjersberg AJ, Spannagl M (2011)
Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - a European Perspective
Thromb Res, 129 (4), 426-33
PubMed 22178575

Bergrem A, Dahm AE, Jacobsen AF, Mowinckel MC, Sandvik L, Sandset PM (2011)
Resistance to activated protein C is a risk factor for pregnancy-related venous thrombosis in the absence of the F5 rs6025 (factor V Leiden) polymorphism
Br J Haematol, 154 (2), 241-7
PubMed 21564075

Enden T, Haig Y, Kløw NE, Slagsvold CE, Sandvik L, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbæk G, Sandset PM, CaVenT Study Group (2011)
Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
Lancet, 379 (9810), 31-8
PubMed 22172244

Ghanima W, Kleven IW, Enden T, Rosales A, Wik HS, Pederstad L, Holme PA, Sandset PM (2011)
Recurrent venous thrombosis, post-thrombotic syndrome and quality of life after catheter-directed thrombolysis in severe proximal deep vein thrombosis
J Thromb Haemost, 9 (6), 1261-3
PubMed 21489133

Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study
Thromb Res, 130 (1), 32-7
PubMed 22178574

Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
The association of inherited thrombophilia and intrauterine fetal death: a case-control study
Blood Coagul Fibrinolysis, 22 (8), 651-6
PubMed 22198364

Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM (2011)
Incidence and risk factors of fetal death in Norway: a case-control study
Acta Obstet Gynecol Scand, 90 (4), 390-7
PubMed 21306337

Kostovski E, Dahm AE, Iversen N, Hjeltnes N, Østerud B, Sandset PM, Iversen PO (2011)
Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium
Blood Coagul Fibrinolysis, 22 (4), 254-9
PubMed 21297449

Lassila R, Antovic JP, Armstrong E, Baghaei F, Dalsgaard-Nielsen J, Hillarp A, Holme PA, Holmström M, Johnsson H, Joutsi-Korhonen L, Sandset PM (2011)
Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia
Semin Thromb Hemost, 37 (3), 328-36
PubMed 21455867

Negaard HF, Sandset PM, Kolset SO, Svennevig K, Østenstad B, Iversen PO (2011)
Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias
Leuk Lymphoma, 52 (6), 1157-9
PubMed 21463121

Pettersen FO, Torheim EA, Dahm AE, Aaberge IS, Lind A, Holm M, Aandahl EM, Sandset PM, Taskén K, Kvale D (2011)
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
J Virol, 85 (13), 6557-66
PubMed 21490090

Stavik B, Skretting G, Aasheim HC, Tinholt M, Zernichow L, Sletten M, Sandset PM, Iversen N (2011)
Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility
BMC Cancer, 11, 357
PubMed 21849050

Tjeldhorn L, Iversen N, Sandvig K, Bergan J, Sandset PM, Skretting G (2011)
Protein C mutation (A267T) results in ER retention and unfolded protein response activation
PLoS One, 6 (8), e24009
PubMed 21901152

Wik HS, Enden TR, Jacobsen AF, Sandset PM (2011)
Long-term quality of life after pregnancy-related deep vein thrombosis and the influence of socioeconomic factors and comorbidity
J Thromb Haemost, 9 (10), 1931-6
PubMed 21848904

Publications 2010

Bergrem A, Jacobsen EM, Skjeldestad FE, Jacobsen AF, Skogstad M, Sandset PM (2010)
The association of antiphospholipid antibodies with pregnancy-related first time venous thrombosis--a population-based case-control study
Thromb Res, 125 (5), e222-7
PubMed 20051285

Dahm AE, Bezemer ID, Sandset PM, Rosendaal FR (2010)
Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis
J Thromb Haemost, 8 (5), 1130-2
PubMed 20149077

Enden T, Storås TH, Negård A, Haig Y, Sandvik L, Gjesdal KI, Sandset PM, Kløw NE (2010)
Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA)
J Magn Reson Imaging, 31 (2), 416-24
PubMed 20099355

Jacobsen AF, Dahm A, Bergrem A, Jacobsen EM, Sandset PM (2010)
Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms
J Thromb Haemost, 8 (11), 2443-9
PubMed 20735725

Krarup LH, Sandset EC, Sandset PM, Berge E (2010)
D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation
Acta Neurol Scand, 124 (1), 40-4
PubMed 20726843

Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR (2010)
Reduced platelet function and role of drugs in acute gastrointestinal bleeding
Basic Clin Pharmacol Toxicol, 108 (3), 194-201
PubMed 21118353

Opstad TB, Eilertsen AL, Høibraaten E, Skretting G, Sandset PM (2010)
Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy
Blood Coagul Fibrinolysis, 21 (6), 516-21
PubMed 20453636

Sandset PM (2010)
Immunobiology of heparin-induced thrombocytopenia
Curr Top Microbiol Immunol, 341, 193-202
PubMed 20369319

Sandset PM, Arnesen H, Jacobsen AF, Wergeland H (2010)
Prophylaxis against prosthetic mitral valve thrombosis with unfractionated heparin administered by an elastometric infusion pump
Thromb Res, 126 (3), e232-4
PubMed 20553950

Sandset PM, Francis C (2010)
Thrombosis Research--affiliation with the European Thrombosis Research Organization (ETRO)
Thromb Res, 125 (1), 1
PubMed 20171348

Skretting G, Stavik B, Landvik NE, Myklebust CF, Iversen N, Zienolddiny S, Sandset PM (2010)
Functional characterization of polymorphisms in the human TFPI gene
Biochem Biophys Res Commun, 397 (1), 106-11
PubMed 20519147

Stavik B, Skretting G, Sletten M, Sandset PM, Iversen N (2010)
Overexpression of both TFPIα and TFPIβ induces apoptosis and expression of genes involved in the death receptor pathway in breast cancer cells
Mol Carcinog, 49 (11), 951-63
PubMed 20886581

Tjeldhorn L, Iversen N, Sandvig K, Bergan J, Sandset PM, Skretting G (2010)
Functional characterization of the protein C A267T mutation: evidence for impaired secretion due to defective intracellular transport
BMC Cell Biol, 11, 67
PubMed 20815936

Publications 2009

Abildgaard U, Sandset PM, Hammerstrøm J, Gjestvang FT, Tveit A (2009)
Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin
Thromb Res, 124 (3), 262-7
PubMed 19162303

Enden T, Kløw NE, Sandvik L, Slagsvold CE, Ghanima W, Hafsahl G, Holme PA, Holmen LO, Njaastad AM, Sandbaek G, Sandset PM, CaVenT study group (2009)
Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency
J Thromb Haemost, 7 (8), 1268-75
PubMed 19422443

Negaard HF, Svennevig K, Kolset SO, Iversen N, Lothe IM, Østenstad B, Sandset PM, Iversen PO (2009)
Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas
Leuk Lymphoma, 50 (6), 998-1004
PubMed 19373600

Sandset PM, Francis C (2009)
Thrombosis Research: Introduction of e-pages
Thromb Res, 124 (3), 251
PubMed 19596224

Sandset PM, Francis C, Key N (2009)
Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)
Thromb Res, 124 (5), 515
PubMed 19837232

Sandset PM, Høibraaten E, Eilertsen AL, Dahm A (2009)
Mechanisms of thrombosis related to hormone therapy
Thromb Res, 123 Suppl 2, S70-3
PubMed 19217481

Tjeldhorn L, Sandset PM, Haugbro K, Skretting G (2009)
Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis
Thromb Res, 125 (3), 230-4
PubMed 19535131

Publications 2008

Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM (2008)
Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method
BJOG, 115 (6), 773-9
PubMed 18355366

Eilertsen AL, Sandvik L, Steinsvik B, Sandset PM (2008)
Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers
J Thromb Haemost, 6 (6), 928-34
PubMed 18394014

Enden T, Garratt AM, Kløw NE, Sandset PM (2008)
Assessing burden of illness following acute deep vein thrombosis: data quality, reliability and validity of the Norwegian version of VEINES-QOL/Sym, a disease-specific questionnaire
Scand J Caring Sci, 23 (2), 369-74
PubMed 19068041

Hofstad B, Nesbakken A, Eritsland J, Brørs O, Sandset PM (2008)
[Should platelet inhibitors be discontinued before gastrointestinal endoscopy?]
Tidsskr Nor Laegeforen, 128 (21), 2440-2
PubMed 19096466

Jacobsen AF, Skjeldestad FE, Sandset PM (2008)
Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study
J Thromb Haemost, 6 (6), 905-12
PubMed 18363820

Negaard HF, Iversen N, Bowitz-Lothe IM, Sandset PM, Steinsvik B, Ostenstad B, Iversen PO (2008)
Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors
Leukemia, 23 (1), 162-9
PubMed 18800145

Negaard HF, Iversen PO, Ostenstad B, Mowinckel MC, Sandset PM (2008)
Increased acquired activated protein C resistance in unselected patients with hematological malignancies
J Thromb Haemost, 6 (9), 1482-7
PubMed 18573186

Negaard HF, Iversen PO, Østenstad B, Iversen N, Holme PA, Sandset PM (2008)
Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor
Thromb Haemost, 99 (6), 1040-8
PubMed 18521506

Skretting G, Lien T, Sandset PM, Iversen N (2008)
Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability
Thromb Res, 123 (6), 851-5
PubMed 19007969

Publications 2007

Andresen MS, Eilertsen AL, Abildgaard U, Sandset PM (2007)
Hormone therapy and raloxifene reduce the coagulation inhibitor potential
Blood Coagul Fibrinolysis, 18 (5), 455-60
PubMed 17581320

Berge E, Haug KB, Sandset EC, Haugbro KK, Turkovic M, Sandset PM (2007)
The factor V Leiden, prothrombin gene 20210GA, methylenetetrahydrofolate reductase 677CT and platelet glycoprotein IIIa 1565TC mutations in patients with acute ischemic stroke and atrial fibrillation
Stroke, 38 (3), 1069-71
PubMed 17290027

Dahm AE, Sandset PM, Rosendaal FR (2007)
The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1
J Thromb Haemost, 6 (2), 393-5
PubMed 18045239

Eilertsen AL, Liestøl S, Mowinckel MC, Hemker HC, Sandset PM (2007)
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system
Thromb Haemost, 97 (6), 938-43
PubMed 17549295

Enden T, Sandvik L, Kløw NE, Hafsahl G, Holme PA, Holmen LO, Ghanima W, Njaastad AM, Sandbaek G, Slagsvold CE, Sandset PM (2007)
Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)
Am Heart J, 154 (5), 808-14
PubMed 17967583

Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Sandset PM (2007)
The association between the proximal extension of the clot and the severity of pulmonary embolism (PE): a proposal for a new radiological score for PE
J Intern Med, 261 (1), 74-81
PubMed 17222170

Ghanima W, Nielssen BE, Holmen LO, Witwit A, Al-Ashtari A, Sandset PM (2007)
Multidetector computed tomography (MDCT) in the diagnosis of pulmonary embolism: interobserver agreement among radiologists with varied levels of experience
Acta Radiol, 48 (2), 165-70
PubMed 17354136

Ghanima W, Sandset PM (2007)
Risk stratification of pulmonary embolism by computed tomography
J Intern Med, 262 (6), 702
PubMed 17944881

Jacobsen AF, Skjeldestad FE, Sandset PM (2007)
Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study
Am J Obstet Gynecol, 198 (2), 233.e1-7
PubMed 17997389

Jensen T, Kierulf P, Sandset PM, Klingenberg O, Joø GB, Godal HC, Skjønsberg OH (2007)
Fibrinogen and fibrin induce synthesis of proinflammatory cytokines from isolated peripheral blood mononuclear cells
Thromb Haemost, 97 (5), 822-9
PubMed 17479194

Liestøl S, Sandset PM, Mowinckel MC, Wisløff F (2007)
Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
J Thromb Haemost, 5 (11), 2204-10
PubMed 17958739

Tchaikovski SN, van Vliet HA, Thomassen MC, Bertina RM, Rosendaal FR, Sandset PM, Helmerhorst FM, Tans G, Rosing J (2007)
Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography
Thromb Haemost, 98 (6), 1350-6
PubMed 18064335

van Vliet HA, Bertina RM, Dahm AE, Rosendaal FR, Rosing J, Sandset PM, Helmerhorst FM (2007)
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor
J Thromb Haemost, 6 (2), 346-51
PubMed 18067603

Publications 2006

Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2006)
Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
Thromb Res, 120 (1), 21-7
PubMed 16914186

Dahm A, Osterud B, Hjeltnes N, Sandset PM, Iversen PO (2006)
Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation?
J Thromb Haemost, 4 (8), 1840-2
PubMed 16879232

Dahm A, Rosendaal FR, Andersen TO, Sandset PM (2006)
Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state
Br J Haematol, 132 (3), 333-8
PubMed 16409298

Dahm AE, Iversen N, Birkenes B, Ree AH, Sandset PM (2006)
Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1
BMC Cardiovasc Disord, 6, 40
PubMed 17029634

Eilertsen AL, Qvigstad E, Andersen TO, Sandvik L, Sandset PM (2006)
Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation
Maturitas, 55 (3), 278-87
PubMed 16713143

Eilertsen AL, Sandvik L, Mowinckel MC, Andersen TO, Qvigstad E, Sandset PM (2006)
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis
Thromb Res, 120 (3), 371-9
PubMed 17156824

Enden T, Kløw NE, Sandset PM (2006)
[Catheter-directed thrombolysis in acute deep venous thrombosis]
Tidsskr Nor Laegeforen, 126 (13), 1765
PubMed 16794675

Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Ross S, Sandset PM (2006)
D-dimer level is associated with the extent of pulmonary embolism
Thromb Res, 120 (2), 281-8
PubMed 17030057

Ghanima W, Abdelnoor M, Mowinckel MC, Sandset PM (2006)
The performance of STA-Liatest D-dimer assay in out-patients with suspected pulmonary embolism
Br J Haematol, 132 (2), 210-5
PubMed 16398655

Ghanima W, Sandset PM (2006)
Validation of a new D-dimer microparticle enzyme immunoassay (AxSYM D-Dimer) in patients with suspected pulmonary embolism (PE)
Thromb Res, 120 (4), 471-6
PubMed 17161451

Husted S, Emanuelsson H, Heptinstall S, Sandset PM, Wickens M, Peters G (2006)
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin
Eur Heart J, 27 (9), 1038-47
PubMed 16476694

Jensen T, Retterstøl LJ, Sandset PM, Godal HC, Skjønsberg OH (2006)
A daily glass of red wine induces a prolonged reduction in plasma viscosity: a randomized controlled trial
Blood Coagul Fibrinolysis, 17 (6), 471-6
PubMed 16905951

Liestøl S, Sandset PM, Jacobsen EM, Mowinckel MC, Wisløff F (2006)
Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants
Br J Haematol, 136 (1), 131-7
PubMed 17092306

Negaard HF, Eilertsen AL, Dahm A, Iversen PO, Østenstad B, Sandset PM (2006)
Decreased lung cancer survival with hormone-replacement therapy: caused by a decreased tissue factor pathway inhibitor level?
J Clin Oncol, 24 (17), 2683-4; author reply 2684
PubMed 16763285

O'Donnell MJ, Berge E, Sandset PM (2006)
Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin?
Stroke, 37 (2), 452-5
PubMed 16410483

Sandset PM (2006)
Hormone replacement therapy and risk of venous thromboembolism--still unresolved questions
J Thromb Haemost, 4 (1), 68-9
PubMed 16409452

Sandset PM (2006)
[How to make warfarin treatment successful?]
Tidsskr Nor Laegeforen, 126 (2), 187
PubMed 16415945

Publications 2005

Dahm AE, Andersen TO, Rosendaal F, Sandset PM (2005)
A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)
J Thromb Haemost, 3 (4), 651-8
PubMed 15842349

Dahm AE, Iversen PO, Hjeltnes N, Sandset PM (2005)
Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured
Thromb Res, 118 (2), 281-7
PubMed 16139333

de Visser MC, van Hylckama Vlieg A, Tans G, Rosing J, Dahm AE, Sandset PM, Rosendaal FR, Bertina RM (2005)
Determinants of the APTT- and ETP-based APC sensitivity tests
J Thromb Haemost, 3 (7), 1488-94
PubMed 15978106

Eilertsen AL, Høibraaten E, Os I, Andersen TO, Sandvik L, Sandset PM (2005)
The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis
Maturitas, 52 (2), 111-8
PubMed 16186073

Ghanima W, Almaas V, Aballi S, Dörje C, Nielssen BE, Holmen LO, Almaas R, Abdelnoor M, Sandset PM (2005)
Management of suspected pulmonary embolism (PE) by D-dimer and multi-slice computed tomography in outpatients: an outcome study
J Thromb Haemost, 3 (9), 1926-32
PubMed 16102097

Haram K, Björge L, Sandset PM (2005)
Successful preconceptional prophylactic treatment with combined acetyl salicylic acid and low-molecular heparin (Fragmin) in a case of antiphospholipid-antibody syndrome with prior life-threatening hemolysis, elevated liver enzymes and low-platelet syndrome: a case report
Acta Obstet Gynecol Scand, 84 (12), 1213-4
PubMed 16305714

Negaard H, Dahm A, Sandset PM, Iversen PO, Østenstad B (2005)
Angiogenesis and hemostasis in hematological neoplasias
Curr Drug Targets, 6 (6), 683-99
PubMed 16178801

Trydal T, Bolann B, Brosstad F, Sandberg S, Sandset PM, Stavelin A, Steensland H, Thue G, Ødegaard OR (2005)
[Analysis of prothrombin time in primary health care]
Tidsskr Nor Laegeforen, 125 (15), 2048-9
PubMed 16100552

Publications 2004

Andresen MS, Abildgaard U, Liestøl S, Sandset PM, Mowinckel MC, Ødegaard OR, Larsen ML, Diep LM (2004)
The ability of three global plasma assays to recognize thrombophilia
Thromb Res, 113 (6), 411-7
PubMed 15226097

Brodin E, Børvik T, Sandset PM, Bønaa KH, Nordøy A, Hansen JB (2004)
Coagulation activation in young survivors of myocardial infarction (MI)--a population-based case-control study
Thromb Haemost, 92 (1), 178-84
PubMed 15213859

Hjort PF, Sandset PM, Abildgaard U, Rao LV, Mast A, Ott I, Bajaj SP (2004)
Tissue factor pathway inhibitor revisited
J Thromb Haemost, 2 (12), 2241-9
PubMed 15613032

Jacobsen AF, Drolsum A, Klow NE, Dahl GF, Qvigstad E, Sandset PM (2004)
Deep vein thrombosis after elective cesarean section
Thromb Res, 113 (5), 283-8
PubMed 15183039

Jensen T, Halvorsen S, Godal HC, Sandset PM, Skjønsberg OH (2004)
The viscosity of fibrinogen subfractions and of EDTA denatured fibrinogen do not differ from that of native fibrinogen
Thromb Res, 113 (1), 51-6
PubMed 15081565

Lindahl TL, Egberg N, Hillarp A, Ødegaard OR, Edlund B, Svensson J, Sandset PM, Rånby M (2004)
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
Thromb Haemost, 91 (6), 1223-31
PubMed 15175811

Russell D, Thomassen L, Indredavik B, Sandset PM, Joakimsen O, Berge E (2004)
[Patients with acute brain infarction should receive thrombolytic therapy]
Tidsskr Nor Laegeforen, 124 (12), 1666-7
PubMed 15229721

Sandset PM (2004)
[Risk of venous thrombosis and smoking]
Tidsskr Nor Laegeforen, 124 (15), 1937
PubMed 15318411

Publications 2003

Bendz B, Sandset PM (2003)
Acute hypoxia and activation of coagulation
Lancet, 362 (9388), 997-8
PubMed 14511938

Dahm A, Van Hylckama Vlieg A, Bendz B, Rosendaal F, Bertina RM, Sandset PM (2003)
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
Blood, 101 (11), 4387-92
PubMed 12560220

Haram K, Trovik J, Sandset PM, Hordnes K (2003)
Severe syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP) in the 18th week of pregnancy associated with the antiphospholipid-antibody syndrome
Acta Obstet Gynecol Scand, 82 (7), 679-80
PubMed 12790854

Jacobsen AF, Qvigstad E, Sandset PM (2003)
Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy
BJOG, 110 (2), 139-44
PubMed 12618157

Os I, Høieggen A, Larsen A, Sandset PM, Djurovic S, Berg K, Os A, Birkeland K, Westheim A (2003)
Smoking and relation to other risk factors in postmenopausal women with coronary artery disease, with particular reference to whole blood viscosity and beta-cell function
J Intern Med, 253 (2), 232-9
PubMed 12542565

Thomassen L, Sandset PM, Joakimsen O, Indredavik B, Russell D (2003)
[Intravenous thrombolytic therapy of patients with acute cerebral infarction]
Tidsskr Nor Laegeforen, 123 (5), 638-9
PubMed 12683192

Publications 2002

Bendz B, Sandset PM (2002)
Air travel and risk of venous thromboembolism
Thromb Res, 108 (1), 15-7
PubMed 12586126

Bendz B, Sandset PM (2002)
[Air travel and venous thrombosis]
Tidsskr Nor Laegeforen, 122 (16), 1579-81
PubMed 12119787

Iversen N, Brandtzaeg P, Sandset PM, Kierulf P, Abildgaard U (2002)
TFPI fractions in plasma from patients with systemic meningococcal disease
Thromb Res, 108 (5-6), 347-53
PubMed 12676197

Iversen PO, Groot PD, Hjeltnes N, Andersen TO, Mowinckel MC, Sandset PM (2002)
Impaired circadian variations of haemostatic and fibrinolytic parameters in tetraplegia
Br J Haematol, 119 (4), 1011-6
PubMed 12472582

Os I, Os A, Sandset PM, Bølling S, Seljeflot I, Djurovic S, Westheim A (2002)
Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine
Cardiology, 98 (1-2), 6-12
PubMed 12373040

Sandset PM (2002)
[Anticoagulant therapy with warfarin--still difficult]
Tidsskr Nor Laegeforen, 122 (10), 992
PubMed 12082707

Sandset PM, Abildgaard U (2002)
Perioperative management of oral anticoagulant therapy
Thromb Res, 108 (1), 1-2
PubMed 12586124

Publications 2001

Bendz B, Sandset PM (2001)
Deep-vein thrombosis in long-haul flights
Lancet, 358 (9284), 837-8; author reply 839
PubMed 11570398

Bendz B, Sevre K, Andersen TO, Sandset PM (2001)
Low molecular weight heparin prevents activation of coagulation in a hypobaric environment
Blood Coagul Fibrinolysis, 12 (5), 371-4
PubMed 11505080

Berge E, Fjaertoft H, Indredavik B, Sandset PM (2001)
Validity and reliability of simple questions in assessing short- and long-term outcome in Norwegian stroke patients
Cerebrovasc Dis, 11 (4), 305-10
PubMed 11385209

Berge E, Friis P, Sandset PM (2001)
Hemostatic activation in acute ischemic stroke
Thromb Res, 101 (2), 13-21
PubMed 11342202

Berge E, Nakstad PH, Sandset PM, HAEST Study Group (2001)
Large middle cerebral artery infarctions and the hyperdense middle cerebral artery sign in patients with atrial fibrillation
Acta Radiol, 42 (3), 261-8
PubMed 11350283

Berge E, Sandset PM (2001)
Heparin and aspirin in stroke
Lancet, 357 (9261), 1044-5
PubMed 11293624

Hansen JB, Grimsgaard S, Huseby N, Sandset PM, Bønaa KH (2001)
Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men
Thromb Res, 102 (1), 3-13
PubMed 11323009

Høibraaten E, Mowinckel MC, de Ronde H, Bertina RM, Sandset PM (2001)
Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial
Br J Haematol, 115 (2), 415-20
PubMed 11703344

Høibraaten E, Qvigstad E, Andersen TO, Mowinckel MC, Sandset PM (2001)
The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial
Thromb Haemost, 85 (5), 775-81
PubMed 11372667

Jonkers IJ, de Man FH, van Tilburg NH, van der Laarse A, Sandset PM, Smelt AH, Bertina RM (2001)
Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a 'procoagulant state': effects of bezafibrate therapy
Blood Coagul Fibrinolysis, 12 (8), 705-12
PubMed 11734672

Publications 2000

Bendz B, Andersen TO, Sandset PM (2000)
Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins
Blood Coagul Fibrinolysis, 11 (4), 343-8
PubMed 10847421

Bendz B, Andersen TO, Sandset PM (2000)
A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1
Thromb Res, 97 (6), 463-72
PubMed 10704656

Bendz B, Rostrup M, Sevre K, Andersen TO, Sandset PM (2000)
Association between acute hypobaric hypoxia and activation of coagulation in human beings
Lancet, 356 (9242), 1657-8
PubMed 11089830

Berge E, Abdelnoor M, Nakstad PH, Sandset PM (2000)
Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial
Lancet, 355 (9211), 1205-10
PubMed 10770301

Hansen JB, Naalsund T, Sandset PM, Svensson B (2000)
Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin
Thromb Res, 100 (5), 413-7
PubMed 11150584

Hansen JB, Svensson B, Sandset PM, Thijssen F (2000)
Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin
Thromb Res, 100 (5), 389-96
PubMed 11150580

Hoibraaten E, Os I, Seljeflot I, Andersen TO, Hofstad A, Sandset PM (2000)
The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study
Thromb Res, 98 (1), 19-27
PubMed 10706930

Høibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrøm E, Sandset PM (2000)
Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)
Thromb Haemost, 84 (6), 961-7
PubMed 11154141

Jacobsen AF, Qvigstad E, Sandset PM (2000)
[Treatment of venous thromboembolism in pregnancy with low molecular weight heparin]
Tidsskr Nor Laegeforen, 120 (20), 2448-9
PubMed 11475236

Jensen T, Halvorsen S, Godal HC, Sandset PM, Skjøonsberg OH (2000)
Discrepancy between fibrinogen concentrations determined by clotting rate and clottability assays during the acute-phase reaction
Thromb Res, 100 (5), 397-403
PubMed 11150581

Lund C, Rygh J, Stensrød B, Sandset PM, Brucher R, Russell D (2000)
Cerebral microembolus detection in an unselected acute ischemic stroke population
Cerebrovasc Dis, 10 (5), 403-8
PubMed 10971027

Nordoy A, Bonaa KH, Sandset PM, Hansen JB, Nilsen H (2000)
Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia
Arterioscler Thromb Vasc Biol, 20 (1), 259-65
PubMed 10634827

Nordøy A, Bønaa KH, Sandset PM, Hansen JB, Nilsen H (2000)
Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia
Nutr Metab Cardiovasc Dis, 10 (1), 15-23
PubMed 10812583

Sandset PM, Bendz B, Hansen JB (2000)
Physiological function of tissue factor pathway inhibitor and interaction with heparins
Haemostasis, 30 Suppl 2, 48-56
PubMed 11251341

Publications 1999

Bendz B, Hansen JB, Andersen TO, Ostergaard P, Sandset PM (1999)
Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins
Br J Haematol, 107 (4), 756-62
PubMed 10606880

Høibraaten E, Abdelnoor M, Sandset PM (1999)
Hormone replacement therapy with estradiol and risk of venous thromboembolism--a population-based case-control study
Thromb Haemost, 82 (4), 1218-21
PubMed 10544901

Jacobsen EM, Sandset PM, Wisløff F (1999)
Do antiphospholipid antibodies interfere with tissue factor pathway inhibitor?
Thromb Res, 94 (4), 213-20
PubMed 10336236

Mariani G, Bernardi F, Bertina R, Vicente VV, Prydz H, Samama M, Sandset PM, Di Nucci GD, Testa MG, Bendz B, Chiarotti F, Ciarla MV, Strom R (1999)
Serum phospholipids are the main environmental determinants of activated factor VII in the most common FVII genotype. European Union Concerted Action "Clotart"
Haematologica, 84 (7), 620-6
PubMed 10406904

Mariani G, Conard J, Bernardi F, Bertina R, Garcia VV, Prydz H, Samama M, Sandset PM, Puopolo M, Ciarla MV, Poso R, Di Nucci GD, Ceci F, Marchetti G (1999)
Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII
Arterioscler Thromb Vasc Biol, 19 (8), 2024-8
PubMed 10446088

Sandset PM (1999)
[Routines for thrombolytic therapy in acute myocardial and cerebral infarction]
Tidsskr Nor Laegeforen, 119 (20), 2977
PubMed 10504841

Schjetlein R, Abdelnoor M, Haugen G, Husby H, Sandset PM, Wisløff F (1999)
Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia
Acta Obstet Gynecol Scand, 78 (3), 191-7
PubMed 10078579

Seidel C, Hjorth-Hansen H, Bendz B, Borset M, Sandset PM, Hansen JB, Sundan A, Waage A (1999)
Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals
Br J Haematol, 105 (3), 641-7
PubMed 10354124

Stensrud G, Passi S, Larsen T, Sandset PM, Smistad G, Mönkkönen J, Karlsen J (1999)
Toxicity of gamma irradiated liposomes. 1. In vitro interactions with blood components
Int J Pharm, 178 (1), 33-46
PubMed 10205623

Publications 1998

Arnesen H, Sandset PM (1998)
[Peroral anticoagulant therapy]
Tidsskr Nor Laegeforen, 118 (18), 2824
PubMed 9748818

Foss Haug KB, Kierulf P, Sandset PM, Urdal P, Wisløff F (1998)
[Hereditary hemochromatosis and use of genetic tests]
Tidsskr Nor Laegeforen, 118 (12), 1911
PubMed 9638063

Hansen JB, Sandset PM (1998)
Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy
Thromb Res, 91 (4), 177-81
PubMed 9736420

Hansen JB, Sandset PM, Huseby KR, Huseby NE, Bendz B, Ostergaard P, Nordøy A (1998)
Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action
Br J Haematol, 101 (4), 638-46
PubMed 9674734

Hem E, Opjordsmoen S, Sandset PM (1998)
[Venous thromboembolism in connection with physical restraint]
Tidsskr Nor Laegeforen, 118 (14), 2156-7
PubMed 9656810

Hervig T, Haram K, Sandset PM (1998)
[Deep venous thrombosis in pregnant women]
Tidsskr Nor Laegeforen, 118 (26), 4093-7
PubMed 9844515

Moland L, Sandset PM (1998)
[Activated protein C resistance--a recently discovered hereditary thrombophilia]
Tidsskr Nor Laegeforen, 118 (23), 3590-5
PubMed 9820002

Sandset PM (1998)
[Monitoring of oral anticoagulant therapy in Norway--recommendations for transfer to the INR system]
Tidsskr Nor Laegeforen, 118 (22), 3443-5
PubMed 9800495

Publications 1997

Bernardi F, Arcieri P, Bertina RM, Chiarotti F, Corral J, Pinotti M, Prydz H, Samama M, Sandset PM, Strom R, Garcia VV, Mariani G (1997)
Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations
Arterioscler Thromb Vasc Biol, 17 (11), 2548-53
PubMed 9409226

Ostergaard PB, Beck TC, Orsted H, Svendsen A, Nordfang O, Sandset PM, Hansen JB (1997)
An enzyme linked immunosorption assay for tissue factor pathway inhibitor
Thromb Res, 87 (5), 447-59
PubMed 9306619

Sandset PM, Bendz B (1997)
Tissue factor pathway inhibitor: clinical deficiency states
Thromb Haemost, 78 (1), 467-70
PubMed 9198198

Sandset PM, Brosstad F (1997)
[Bleeding time indication in invasive and surgical interventions]
Tidsskr Nor Laegeforen, 117 (2), 191
PubMed 9064829

Schjetlein R, Haugen G, Sandset PM, Wisløff F (1997)
Reduced C4b-binding protein in preeclampsia
Thromb Res, 85 (2), 153-8
PubMed 9058489

Publications 1996

Abildgaard U, Sandset PM (1996)
[Clexane (enoxaparin) or Fragmin (dalteparin) as thrombolytics in hip surgery? Is Fragmin better than Clexane?]
Tidsskr Nor Laegeforen, 116 (19), 2351; author reply 2352
PubMed 8804214

Hansen JB, Sandset PM, Huseby KR, Huseby NE, Nordøy A (1996)
Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man
Thromb Haemost, 76 (5), 703-9
PubMed 8950777

Iversen N, Sandset PM, Abildgaard U, Torjesen PA (1996)
Binding of tissue factor pathway inhibitor to cultured endothelial cells-influence of glycosaminoglycans
Thromb Res, 84 (4), 267-78
PubMed 8948051

Jacobsen EM, Sandset PM, Wisløff F (1996)
Lupus anticoagulant and a functional assay for tissue factor pathway inhibitor
Thromb Res, 83 (4), 339-40
PubMed 8870178

Jensenius M, Holm B, Calisch TE, Haugen K, Sandset PM (1996)
[Deep venous thrombosis in intravenous drug addicts]
Tidsskr Nor Laegeforen, 116 (21), 2556-8
PubMed 8928124

Sandset PM (1996)
Tissue factor pathway inhibitor (TFPI)--an update
Haemostasis, 26 Suppl 4, 154-65
PubMed 8979119

Sandset PM (1996)
[Thromboembolytic therapy in acute stroke]
Tidsskr Nor Laegeforen, 116 (27), 3205-6
PubMed 9011967

Publications 1995

Arnesen H, Sandset PM, Eritsland J (1995)
[Fat-soluble vitamins in clinical practice]
Tidsskr Nor Laegeforen, 115 (7), 870
PubMed 7701499

Dahl T, Abildgaard U, Sandset PM (1995)
Long-term anticoagulant therapy in cerebrovascular disease: does bleeding outweigh the benefit?
J Intern Med, 237 (3), 323-9
PubMed 7891054

Eritsland J, Gjønnes G, Sandset PM, Seljeflot I, Arnesen H (1995)
Activated protein C resistance and graft occlusion after coronary artery bypass surgery
Thromb Res, 79 (2), 223-6
PubMed 7676409

Hansen JB, Huseby KR, Huseby NE, Sandset PM, Hanssen TA, Nordøy A (1995)
Effect of cholesterol lowering on intravascular pools of TFPI and its anticoagulant potential in type II hyperlipoproteinemia
Arterioscler Thromb Vasc Biol, 15 (7), 879-85
PubMed 7600119

Publications 1994

Hansen JB, Huseby NE, Sandset PM, Svensson B, Lyngmo V, Nordøy A (1994)
Tissue-factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma
Arterioscler Thromb, 14 (2), 223-9
PubMed 8305412

Lindahl AK, Sandset PM, Thune-Wiiger M, Nordfang O, Sakariassen KS (1994)
Tissue factor pathway inhibitor prevents thrombus formation on procoagulant subendothelial matrix
Blood Coagul Fibrinolysis, 5 (5), 755-60
PubMed 7865681

Publications 1993

Heldal M, Seem E, Sandset PM, Abildgaard U (1993)
Deep vein thrombosis: a 7-year follow-up study
J Intern Med, 234 (1), 71-5
PubMed 8326292

Publications 1992

Callander NS, Rao LV, Nordfang O, Sandset PM, Warn-Cramer B, Rapaport SI (1992)
Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa
J Biol Chem, 267 (2), 876-82
PubMed 1730676

Dahl T, Sandset PM, Abildgaard U (1992)
[A cerebrovascular unit. Experiences after 8-years of activity]
Tidsskr Nor Laegeforen, 112 (15), 1974-6
PubMed 1509463

Lindahl AK, Odegaard OR, Sandset PM, Harbitz TB (1992)
Coagulation inhibition and activation in pancreatic cancer. Changes during progress of disease
Cancer, 70 (8), 2067-72
PubMed 1394036

Lindahl AK, Sandset PM, Abildgaard U (1992)
The present status of tissue factor pathway inhibitor
Blood Coagul Fibrinolysis, 3 (4), 439-49
PubMed 1420819

Publications 1991

Abildgaard U, Lindahl AK, Sandset PM (1991)
Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood
Haemostasis, 21 (4), 254-7
PubMed 1794751

Lindahl AK, Abildgaard U, Larsen ML, Staalesen R, Hammer AK, Sandset PM, Nordfang O, Beck TC (1991)
Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI
Thromb Res, 62 (6), 607-14
PubMed 1926055

Lindahl AK, Jacobsen PB, Sandset PM, Abildgaard U (1991)
Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients
Blood Coagul Fibrinolysis, 2 (6), 713-21
PubMed 1799658

Russell D, Madden KP, Clark WM, Sandset PM, Zivin JA (1991)
Detection of arterial emboli using Doppler ultrasound in rabbits
Stroke, 22 (2), 253-8
PubMed 2003290

Sandset PM, Abildgaard U (1991)
Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin
Haemostasis, 21 (4), 219-39
PubMed 1794748

Sandset PM, Larsen ML, Abildgaard U, Lindahl AK, Odegaard OR (1991)
Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol
Blood Coagul Fibrinolysis, 2 (3), 425-33
PubMed 1932528

Sandset PM, Lund H, Norseth J, Abildgaard U, Ose L (1991)
Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system
Arterioscler Thromb, 11 (1), 138-45
PubMed 1987991

Sandset PM, Warn-Cramer BJ, Maki SL, Rapaport SI (1991)
Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction
Blood, 78 (6), 1496-502
PubMed 1909195

Sandset PM, Warn-Cramer BJ, Rao LV, Maki SL, Rapaport SI (1991)
Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant
Proc Natl Acad Sci U S A, 88 (3), 708-12
PubMed 1899482

Publications 1990

Abildgaard U, Norrheim L, Larsen AE, Nesvold A, Sandset PM, Odegaard OR (1990)
Monitoring therapy with LMW heparin: a comparison of three chromogenic substrate assays and the Heptest clotting assay
Haemostasis, 20 (4), 193-203
PubMed 2173672

Lindahl AK, Sandset PM, Abildgaard U (1990)
Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarction
Haemostasis, 20 (5), 253-62
PubMed 2289706

Sandset PM, Dahl T, Stiris M, Rostad B, Scheel B, Abildgaard U (1990)
A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke
Semin Thromb Hemost, 16 Suppl, 25-33
PubMed 1962901

Publications 1989

Abildgaard U, Dahl T, Sandset PM (1989)
[Atrial fibrillation: an indication to prevent stroke]
Tidsskr Nor Laegeforen, 109 (22), 2183
PubMed 2772888

Brandtzaeg P, Sandset PM, Joø GB, Ovstebø R, Abildgaard U, Kierulf P (1989)
The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease
Thromb Res, 55 (4), 459-70
PubMed 2510354

Dahl T, Lindboe CF, Sandset PM, Rostad B, Abildgaard U (1989)
Fatalities in a stroke unit
J Oslo City Hosp, 39 (3), 31-7
PubMed 2723877

Lindahl AK, Sandset PM, Abildgaard U, Andersson TR, Harbitz TB (1989)
High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer
Acta Chir Scand, 155 (8), 389-93
PubMed 2596246

Sandset PM, Abildgaard U, Hedner U, Johansson H (1989)
Extrinsic coagulation pathway inhibitor during recombinant factor VIIa infusion
Thromb Haemost, 62 (4), 1146
PubMed 2617462

Sandset PM, Andersson TR (1989)
Coagulation inhibitor levels in pneumonia and stroke: changes due to consumption and acute phase reaction
J Intern Med, 225 (5), 311-6
PubMed 2471768

Sandset PM, Hellgren M, Uvebrandt M, Bergström H (1989)
Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy
Thromb Res, 55 (5), 665-70
PubMed 2814949

Sandset PM, Høgevold HE, Lyberg T, Andersson TR, Abildgaard U (1989)
Extrinsic pathway inhibitor in elective surgery: a comparison with other coagulation inhibitors
Thromb Haemost, 62 (3), 856-60
PubMed 2595660

Sandset PM, Røise O, Aasen AO, Abildgaard U (1989)
Extrinsic pathway inhibitor in postoperative/posttraumatic septicemia: increased levels in fatal cases
Haemostasis, 19 (4), 189-95
PubMed 2807038

Sandset PM, Sirnes PA, Abildgaard U (1989)
Factor VII and extrinsic pathway inhibitor in acute coronary disease
Br J Haematol, 72 (3), 391-6
PubMed 2788454

Publications 1988

Abildgaard U, Sandset PM, Andersson TR, Odegaard OR, Rosĕn S (1988)
The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material
Folia Haematol Int Mag Klin Morphol Blutforsch, 115 (3), 274-7
PubMed 2465215

Sandset PM, Abildgaard U, Larsen ML (1988)
Heparin induces release of extrinsic coagulation pathway inhibitor (EPI)
Thromb Res, 50 (6), 803-13
PubMed 3413731

Publications 1987

Sandset PM, Abildgaard U, Pettersen M (1987)
A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions
Thromb Res, 47 (4), 389-400
PubMed 3499007

Publications 1986

Dahl T, Sandset PM, Toska K, Abildgaard U (1986)
Heparin treatment of acute stroke
J Oslo City Hosp, 36 (12), 133-7
PubMed 3819917

Sandset PM, Ostensjø R, Dahl T, Abildgaard U (1986)
Acute stroke treated in a cerebrovascular unit
J Oslo City Hosp, 36 (12), 123-31
PubMed 3819916